2011
DOI: 10.1186/1741-7007-9-65
|View full text |Cite
|
Sign up to set email alerts
|

Drosophila insulin and target of rapamycin (TOR) pathways regulate GSK3 beta activity to control Myc stability and determine Myc expression in vivo

Abstract: BackgroundGenetic studies in Drosophila melanogaster reveal an important role for Myc in controlling growth. Similar studies have also shown how components of the insulin and target of rapamycin (TOR) pathways are key regulators of growth. Despite a few suggestions that Myc transcriptional activity lies downstream of these pathways, a molecular mechanism linking these signaling pathways to Myc has not been clearly described. Using biochemical and genetic approaches we tried to identify novel mechanisms that co… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
58
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 61 publications
(59 citation statements)
references
References 58 publications
0
58
0
Order By: Relevance
“…If Myc’s regulation of cellular growth rate is key to its ability to modulate lifespan, it is tempting to suggest that this may be via the Insulin (IIS) signaling pathway that has been previously implicated in aging across a number of species [53]. Myc can regulate the IIS downstream target gene eIF4E in mammalian cells [54], [55], and has been linked to both Foxo and TOR in flies, although this appears to be highly tissue-specific [56], [57]. Myc may therefore be a new component to this highly conserved lifespan/aging pathway.…”
Section: Discussionmentioning
confidence: 99%
“…If Myc’s regulation of cellular growth rate is key to its ability to modulate lifespan, it is tempting to suggest that this may be via the Insulin (IIS) signaling pathway that has been previously implicated in aging across a number of species [53]. Myc can regulate the IIS downstream target gene eIF4E in mammalian cells [54], [55], and has been linked to both Foxo and TOR in flies, although this appears to be highly tissue-specific [56], [57]. Myc may therefore be a new component to this highly conserved lifespan/aging pathway.…”
Section: Discussionmentioning
confidence: 99%
“…dMyc is another important mediator of nutritional gene expression, particularly the transcription of genes involved in ribosome biogenesis (Grewal et al, 2005;Li et al, 2010;Teleman et al, 2008). Both the insulin/PI3K and TOR branches of the nutrient-sensing pathway can regulate Myc, at the mRNA and protein levels respectively (Parisi et al, 2011;Teleman et al, 2008). Further transcription factors known to regulate gene expression downstream of TOR include SREBP, involved in lipid and sterol biosynthesis, and Sugarbabe, which mediates the effect of nutrient deprivation on dILP release (Porstmann et al, 2008;Varghese et al, 2010).…”
Section: Introductionmentioning
confidence: 99%
“…Unlike c-Myc, which was shown to have a single Myc BoxI phosphodegron associated with Fbw7 binding, several domains containing putative Ago-interacting motifs were shown in dMyc to mediate Casein kinase 1 (CK1)α-, CK1ε-and GSK3β-dependent protein degradation. Although their link to Ago function has not been precisely established, it is clear that GSK3β plays a key role in Ago-mediated dMyc ubiquitylation and degradation (Galletti et al, 2009;Moberg et al, 2004;Parisi et al, 2011).…”
Section: Introductionmentioning
confidence: 99%